ICHR just made new 52-week highs after guiding higher.
Ichor (NASDAQ:ICHR) announced Q4 revenue of 189M (+22% Q/Q) versus the 184.9M consensus.
The company expects positive cash flow from operations, with 61M in cash at the end of the year and 181M in total debt.
For Q1, Ichor sees total sales of $210-230M, above the 181.9M consensus.
Ichor will report earnings on February 5.
B. Riley (Buy) raises its Ichor (NASDAQ:ICHR) target from $40 to $45 after yesterday's preliminary Q4 results.
The firm was "pleasantly surprised with the revision and F1Q20’s upside magnitude" and sees the potential for strong "margin leverage and powerful EPS follow-through."
DA Davidson (Buy) lifts Ichor from $38 to $40, noting that the "monster" outlook implies that Q1 "will be the third largest revenue quarter in the company’s history."
Lam Research (LRCX +0.6%) and Applied Materials (AMAT +0.9%) are up after the outlook since the companies account for 56% and 32% of Ichor's revenue, respectively, according to Bloomberg data.
As always, use protective stops and trade with caution.